Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-09-26
2000-09-19
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424400, 514 44, 514938, 935 54, A61K 9107, A61K 9127
Patent
active
061207942
ABSTRACT:
New emulsion and micelle formulations are described as are complexes of these formulations with biologically active substances. The novel formulations are different from cationic lipid vectors such as cationic liposomes in that the complexes formed between biologically active substances and the emulsion and micellar formulations of this invention are physically stable and their transfection activity is resistant to the presence of serum. These novel formulations are disclosed to be useful in areas such as gene therapy or vaccine delivery.
REFERENCES:
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4958013 (1990-09-01), Letsinger
patent: 5043164 (1991-08-01), Huang et al.
patent: 5100662 (1992-03-01), Bolcsak et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5279833 (1994-01-01), Rose
patent: 5283185 (1994-02-01), Epand
patent: 5286634 (1994-02-01), Stadler
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5366737 (1994-11-01), Eppstein et al.
patent: 5374548 (1994-12-01), Caras
patent: 5523222 (1996-06-01), Page et al.
patent: 5540933 (1996-07-01), Ruoslahti et al.
patent: 5545412 (1996-08-01), Eppstein et al.
patent: 5578475 (1996-11-01), Jesse
patent: 5635487 (1997-06-01), Wolf
patent: 5661025 (1997-08-01), Szoka, Jr. et al.
patent: 5705385 (1998-01-01), Bally
patent: 5795587 (1998-08-01), Gao et al.
patent: 5844107 (1998-12-01), Hanson et al.
patent: 5877302 (1999-03-01), Hanson et al.
patent: 5885613 (1999-03-01), Holland
patent: 5972900 (1999-10-01), Ferkol, Jr. et al.
patent: 5972901 (1999-10-01), Ferkol, Jr. et al.
patent: 6008202 (1999-12-01), Huang et al.
patent: 6008336 (1999-12-01), Hanson et al.
Behr et al. (Sep. 1989). "Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA," Proc. Natl. Acad. Sci. USA 86:6982-6986.
Cheetham et al. (1990). "Cholesterol sulfate inhibits the fusion of sendai virus to biological and model membranes," J. Biol. Chem. 256:12404-12409.
Demeneix. (Mar. 1994). "Temporal and spatial expression of lipospermine-compacted genes transferred into chick embryos in vivo," BioTechniques 16:496-501.
Felgner et al. (Nov. 1987). "Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure," Proc. Natl. Acad. Sci. USA 84:7413-7417.
Gao et al. (1991). "A novel cationic liposome reagent for efficient transfection of mammalian cells," Biochem. Biophy. Res. Commun. 179(1):280-285.
Hui et al. (Nov. 1994). Induction of alloreactive cytotoxic T lymphocytes by intrasplenic immunization with allogenic class I major histocompatiblity complex DNA and DC-chol cationic liposomes, J. Liposome Res. 4(3):1077-1078.
Letsinger et al. (Sep. 1989). "Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture," Proc. Natl. Acad. Sci. USA 86:6553-6556.
Malone. (1989). "Cationic liposome-mediated RNA transfection," Proc. Natl. Acad. Sci. USA 86:6077-6081.
Philip et al. (1993). "In vivo gene delivery" J. Biol. Chem. 268(22):16087-16090.
Pinnaduwage. (1989). "Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells," Biochim. Biophys. Acta 985(1):33-37.
Rajaonarivony et al. (Sep. 1993). "Development of a new drug carrier made from alginate," J. Pharm. Sci. 82(9):912-917.
Rose et al. (Apr. 1999). "A new cationic liposome reagent mediating nearly quantitative transfection of animal cells," BioTechniques 10:520-525.
Stamatatos et al. (1988). "Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes," Biochemistry 27:3917-3925.
Sternberg. (1994). "New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy," FEBS Lett. 356:361-366.
Stewart et al. (Jun. 1992). "Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice," Hum. Gene Ther. 3:267-275.
Stribling et al. (Dec. 1992). "Aerosol gene delivery in vivo" PNAS USA 89:11277-11281.
Zhou (1991). "Lipophilic polylysines mediate efficient DNA transfection in mammalian cells," Biochim. Biophys. Acta 1065(1):8-14.
Patent Abstracts of japan, vol. 18. No. 337 (c-1217), Jun. 27, 1994 and Database WPI, Section Ch, Week 9416, Derwent Publications Ltd., London, GB; Class B-05, AN 94-131963 (1996).
Chemical Abstracts, vol. 121, No. 9, Aug. 29, 1994, Columbus, Ohio, US; abstract No. 109565, Yamada, H.: "Preparation of liposomes containing glycosides".
J. Colloid Interface Sci., vol. 125, No. 1, 1988, pp. 261-270, XP000645802, Treiner C., et al., "Micellar solubilization in aqueous binary surfactant systems : barbituric acids in mixed anionic+nonionic or cationic+nonionic mixtures".
Biochim, Biophys. Acta., vol. 1111, No. 2. 1992, pp. 239-246, XP000607577, Farhood H. et al., "Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity".
Biochemestry, vol. 31, 1992, pp. 9025-9030, XP000645334, Bottega R. et al; "Inhabition of protein kinase C by cationic amphiphiles".
Huang Leaf
Liu Dexi
Liu Feng
Yang Jing-Ping
Kishore Gollamudi S.
University of Pittsburgh
LandOfFree
Emulsion and micellar formulations for the delivery of biologica does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Emulsion and micellar formulations for the delivery of biologica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Emulsion and micellar formulations for the delivery of biologica will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1069605